Who invested in InSitu Biologics

4 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised this month

Follow InSitu Biologics and see its new rounds in your feed. Start following

Funding summaryUpdated 15 Nov 2026

$22Mraised across 4 rounds since 2018, from 9 sources

$2.0MSeries A$4.0MRound$1.3MRound$15MRound

Latest round: Round, $15MNov 2026
Step-upi: 12×
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202220242026

$2.0MSeries A$4.0MRound$1.3MRound$15MRound

First round: Series A, $2.0M
Biggest round: $15M
Usual gap between rounds: 9 months

The rounds

Nov 2026
Round$15M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yet and 5 othersSEC filing: $15M sold, first sale Nov 2026
Aug 2026
Round$1.3M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.3M sold, first sale Aug 2026
Nov 2025
Round$4.0M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $4.0M sold, first sale Nov 2025
Dec 2018
Series A$2.0M
No investor was named in the report.
Reported by FinSMEs

Funding filed with regulators

InSitu Biologics filed 6 raises, $29M in all. Filings say how much was sold and to how many investors; they never name the investors.

Nov 2026$15M27 investorsof $20M offeredSEC Form D
Oct 2026$1.3M1 investorof $3.4M offeredSEC Form D
Aug 2026$1.3M1 investorof $2.5M offeredSEC Form D
Nov 2025$4.0M29 investorsof $8.0M offeredSEC Form D
Dec 2023$3.0M1 investordebt, options, securities on exerciseSEC Form D
Jun 2020$5.0M22 investorsdebt, options, securities on exerciseof $5.5M offeredSEC Form D